With advances in T-cell therapy garnering global interest, we spoke with Michael Kalos, Chief Scientific Officer of Cancer Immunobiology, on the future of adoptive T-cell therapies.
  • Name *
  • Job Title *
  • Company *
  • Email *
  • Phone *
  • Country *
  •  Yes, sign me up for the Adoptive T-Cell USA e-newsletter, including information on Podcasts, Interviews, event discounts and other learning opportunities.
    • captcha